Understanding Long-Term Medication Use with Markov Analysis
Author Information
Author(s): Menckeberg Tanja T, Belitser Svetlana V, Bouvy Marcel L, Bracke Madelon, Lammers Jan-Willem J, Raaijmakers Jan AM, Leufkens Hubert GM
Primary Institution: Utrecht Institute for Pharmaceutical Sciences (UIPS), Utrecht, The Netherlands
Hypothesis
Can a Markov model effectively describe the patterns of long-term inhaled corticosteroid use in patients with chronic conditions?
Conclusion
The Markov model reveals that new users of inhaled corticosteroids have lower probabilities of continuous use and more variability in their medication patterns compared to previous users.
Supporting Evidence
- New users had a lower probability of continuous use (7.7%) compared to previous users (56%).
- 51% of new users continued ICS use in the first two years, increasing to over 70% in subsequent years.
- Medication gaps of 1-8 years were observed in 69.1% of new users.
Takeaway
This study looks at how people use asthma medication over a long time and finds that new users often stop and start their medication more than those who have used it before.
Methodology
A Markov model was used to analyze prescription refill patterns over a ten-year period for patients who filled at least one inhaled corticosteroid prescription in 1993.
Potential Biases
Potential confounding factors related to patient history and medication use patterns may affect the results.
Limitations
The study relies on prescription data, which may not capture all aspects of medication adherence.
Participant Demographics
{"new_users":{"count":3367,"mean_age":43.9,"male_percentage":48.4},"previous_users":{"count":5481,"mean_age":50.7,"male_percentage":51.3}}
Statistical Information
P-Value
p<0.05
Confidence Interval
95% C.I. 22.1–26.0%
Statistical Significance
p<0.05
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website